Astrazeneca AZN
NYSE AZN
$184.97 -1.79 (-0.96%)
As of: Nov 11, 2026 · 1:50 PM EST

Astrazeneca (AZN) Cash from Operations (2009 - 2025)

Updated

Astrazeneca's Cash from Operations was $4.67 billion in Q3 2026, down 9.1% from $5.13 billion a year earlier but up 62.9% from the prior quarter.

Analysis

Astrazeneca (AZN) Cash from Operations (2009 - 2025) Analysis & Trends

On a trailing twelve-month basis, Astrazeneca's Cash from Operations was $13.23 billion through Sep 30, 2026, down 12.6% year-over-year; for FY2025, it came in at $14.58 billion, up 22.9% from FY2024.

  • Cash from Operations has now increased for seven consecutive years, with a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was $11.86 billion in FY2024 (+14.7%), $10.35 billion in FY2023 (+5.5%), $9.81 billion in FY2022 (+64.5%) and $5.96 billion in FY2021 (+24.3%).
  • Quarterly Cash from Operations has moved between $1.25 billion (Q2 2022) and $5.13 billion (Q3 2025) over five years.
  • Compared with a year earlier, Cash from Operations has declined for four straight quarters, with growth averaging 8.2% over the last seven quarters.
  • The best year-over-year quarter for Cash from Operations over five years was Q2 2024 (growth of 79.6%); the worst was Q4 2021 (a decline of 21.1%).
  • Per Business Quant data, AZN's Cash from Operations in the three quarters before Q3 2026 was $2.87 billion (Q2 2026), $3.36 billion (Q1 2026) and $2.34 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Yr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 16.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 19.03 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 16.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 19.14 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 14.58 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.96 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 10.02 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.70 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 3.63 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.58 Bn
Dec 31, 2024 11.86 Bn
Dec 31, 2023 10.35 Bn
Dec 31, 2022 9.81 Bn
Dec 31, 2021 5.96 Bn
Dec 31, 2020 4.80 Bn
Dec 31, 2019 2.97 Bn
Dec 31, 2018 2.62 Bn
Dec 31, 2017 3.58 Bn
Dec 31, 2016 4.15 Bn
Dec 31, 2015 3.32 Bn
Dec 31, 2014 7.06 Bn
Dec 31, 2013 7.40 Bn
Dec 31, 2012 6.95 Bn
Dec 31, 2011 7.82 Bn
Dec 31, 2010 10.68 Bn
Dec 31, 2009 11.74 Bn
API Access

Astrazeneca Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations-annual&ticker=AZN&period=max&api_key=YOUR_API_KEY